Abstract:GATA2 coding and noncoding germline mutations cause GATA2 deficiency syndrome, often leading to myelodysplastic syndrome and acute myeloid leukemia. We demonstrated that GATA2 deficiency in murine fetal liver progenitors resulting from loss of Gata2 -77 enhancer upregulates components of Interferon-gamma (IFNg) and Toll-like receptor (TLR) signaling pathways. Using a genetic rescue system, we demonstrated that GATA2-deficient fetal progenitors are hypersensitive to IFNg and TLR1/2 agonist through signaling crosstalk to establish an aberrant transcriptional state. This elevated innate immune signaling is associated with disrupted hematopoiesis and retention of monocytic differentiation ex vivo. GATA2 deficiency elevated expression of select B-lineage and myeloid genes via a PU.1-dependent mechanism. To test the hypothesis that PU.1 is required to establish an ectopic signaling state in GATA2-deficient progenitors, we deleted Spi1 -14 kb enhancer, reducing PU.1 expression ∼50%, and tested whether PU.1 is critical, contributory, or not required for IFNg- and TLR-dependent genomic responses. RNA-seq analysis revealed that PU.1 loss abrogated TLR1/2-dependent transcriptional regulation. By contrast, PU.1 loss attenuated certain, but not all, IFNg-mediated transcriptional responses or responses to synergistic signaling. Multiomic studies are parsing GATA2 and PU.1 target genes as signal-dependent or -independent and establishing mechanisms rendering a given gene regulated by GATA2, PU.1, individual pathways, and/or synergistic signaling. In aggregate, these studies support a model in which GATA2 levels dictate genome responsiveness to the innate immune signaling milieu, and elucidating the mechanisms will unveil new concepts of how hematopoietic regulators dictate genome responsiveness to a dynamically changing signaling environment in physiological and pathologic contexts.

Restoration of Lipopolysaccharide-Mediated B-cell Response after Expression of a Cdna Encoding a GTP-binding Protein

Enhanced B Cell Receptor Signaling Partially Compensates for Impaired Toll-like Receptor 4 Responses in LPS-Stimulated IκBNS-Deficient B Cells

Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression

Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria

Purification and characterization of murine lipopolysaccharide-binding protein

A Sensitized Genetic System For The Analysis Of Murine B Lymphocyte Signal Transduction Pathways Dependent On Bruton'S Tyrosine Kinase

LPS Stimulates IgM Production in Vivo Without Help from Non-B Cells

Progressive Depletion of Peripheral B Lymphocytes in 4-1Bb (cd137) Ligand/I-E-Alpha-Transgenic Mice

Humoral Responses Require a Multi-Stage T:B Lymphocyte Interaction Process (99.5)

Gm40600 promotes CD4+ T-cell responses by interacting with Ahnak

Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins

3010 – MOLECULAR DETERMINANTS OF INNATE IMMUNE SIGNAL-DEPENDENT GENOME RESPONSIVENESS IN HEMATOPOIETIC PROGENITOR CELLS

Upregulated selenoprotein I during lipopolysaccharide-induced B cell activation promotes lipidomic changes and is required for effective differentiation into IgM-secreting plasma B cells

Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin

TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice

CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease

Molecular characterization and functional analysis of the bactericidal permeability-increasing protein/LPS-binding protein (BPI/LBP) from roughskin sculpin (Trachidermus fasciatus)

Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4

Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium Tuberculosis Infection

PI3K- and PTEN-Governed PIP2 and PIP3 Equilibrium Regulates the Activation and Function of B Cells Through Dock2 Controlled Growth of Antigen Receptor Microclusters

Identification of a Unique Hybrid Macrophage-Polarization State following Recovery from Lipopolysaccharide Tolerance